Tags: Regeneron | Replace | MetroPCS | S&P

Regeneron to Replace MetroPCS in S&P 500 Index

Wednesday, 24 Apr 2013 06:03 PM

Regeneron Pharmaceuticals Inc., maker of the Eylea eye medicine, will replace MetroPCS Communications Inc. in the Standard & Poor’s 500 Index, S&P said in a statement Wednesday.

The change will take place after the close of trading on April 30, S&P said.

MetroPCS is merging with Deutsche Telekom AG’s T-Mobile USA Inc. in a transaction that is expected to leave the combined company’s public float below the 50 percent threshold needed for inclusion in the index, S&P said. MetroPCS shareholders approved the sweetened deal Wednesday in a crucial vote that gives Deutsche Telekom a chance to revive its U.S. business.

© Copyright 2017 Bloomberg News. All rights reserved.

   
1Like our page
2Share
InvestingAnalysis
Regeneron Pharmaceuticals Inc., maker of the Eylea eye medicine, will replace MetroPCS Communications Inc. in the Standard Poor s 500 Index, S P said in a statement Wednesday.The change will take place after the close of trading on April 30, S P said.MetroPCS is merging...
Regeneron,Replace,MetroPCS,S&P
100
2013-03-24
Wednesday, 24 Apr 2013 06:03 PM
Newsmax Inc.
 

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
MONEYNEWS.COM
© Newsmax Media, Inc.
All Rights Reserved